Holifya secures €2m to expand AI-supported obesity care
The Italian digital clinic will strengthen its data and clinical teams as it combines diagnostics, medical supervision and personalized follow-up for obesity treatment.
A care pathway around obesity medication
Holifya combines genetic, blood-chemistry and medical-history biomarkers with behavioral and clinical information to support physicians treating obesity and metabolic syndrome. Its care team provides consultations, nutrition and lifestyle guidance, and ongoing monitoring; when a doctor determines it is appropriate, medication can be prescribed and followed up through the programme.
The €2 million financing will strengthen Holifya’s technology and data team, support proprietary AI models, expand distribution partnerships and grow its clinical team. The company says it has treated more than 3,000 patients, and its platform is designed to help physicians monitor tolerability, adjust treatment and maintain follow-up rather than leave patients to navigate care alone.
Use of funds
Strengthen the technology and data team and develop proprietary AI models
Support consumer growth and strategic distribution partnerships
Expand the clinical team